Showing 1 - 10 of 136
condition for designing effective policies is to identify who drives antibiotic treatment decisions, physicians or patient … demand. We measure the causal effect of physician practice style on antibiotic intake and health outcomes exploiting …
Persistent link: https://www.econbiz.de/10013218285
This paper investigates the effect of physicians on infant mortality, stillbirths and the incidence of common childhood … endogeneity of health care supply is addressed by using the expulsion of Jewish physicians from health insurance schemes by the … control function approach. Our results indicate that the marginal returns to physicians are highly nonlinear and decreasing …
Persistent link: https://www.econbiz.de/10012908713
expulsion of Jewish physicians from statutory health insurance as exogenous variation in regional physician supply. Increases in … the supply of physicians reduce infant mortality and mortality from common childhood diseases. Using a semiparametric …
Persistent link: https://www.econbiz.de/10013292046
In many markets supply contracts include a series of small, regular payments made by consumers and a single, large bonus that consumers receive at some point during the contractual period. But, if for instance its production costs exceed its value to consumers, such a bonus creates...
Persistent link: https://www.econbiz.de/10012890631
there is substantial variation in the quality of physicians, as measured by patients’ post-assignment mortality, in the …
Persistent link: https://www.econbiz.de/10014082234
We analyze prescription behavior of physicians in the public and private sector. We study two major diseases for which … private sector physicians are more likely to prescribe the expensive medication. The result holds after controlling for … our cases, we further find that the same physicians prescribe different medication when working in different sectors …
Persistent link: https://www.econbiz.de/10014263219
We study the moral hazard effects of the drug copayment threshold in Finland using detailed prescription drug purchase data. The analysis reveals that the average drug costs increase discontinuously by 17% at the threshold above which out-of-pocket drug costs decrease substantially. Our results...
Persistent link: https://www.econbiz.de/10014347995
pricing system was changed in 2011 in order to tie prices more to the benefits of the pharmaceuticals. A multiple linear … regression of 187 pharmaceuticals which were assessed from 2011 to 2017 suggests that, despite the change, the manufacturers …
Persistent link: https://www.econbiz.de/10012860771
A non-trivial fraction of people cannot afford to buy pharmaceutical products at unregulated market prices. Therefore, the paper analyzes the public insurance of the pharmaceutical products in terms of price controls and the socially optimal third-degree price discrimination. It characterizes...
Persistent link: https://www.econbiz.de/10012843430
This paper provides insights into the determinants of bargaining power and how they affect drug prices. Our data show that drug prices vary across buyers and time periods. We estimate a structural bargaining model where drug suppliers and buyers engage in bilateral bargaining over drug prices....
Persistent link: https://www.econbiz.de/10012845687